{"id":1619,"date":"2023-01-09T08:00:00","date_gmt":"2023-01-09T07:00:00","guid":{"rendered":"https:\/\/d3glparxwv1yl3.cloudfront.net\/annualreport\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/"},"modified":"2023-05-23T14:11:18","modified_gmt":"2023-05-23T14:11:18","slug":"ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/","title":{"rendered":"Ipsen acquiert Albireo, pour acc\u00e9l\u00e9rer sa croissance dans les Maladies Rares afin de traiter les maladies du foie chez l\u2019enfant"},"content":{"rendered":"<p><strong>PARIS, FRANCE &amp; BOSTON, \u00c9TATS-UNIS,\u00a0<\/strong>le 9\u00a0janvier\u00a02023 \u2013 Ipsen (Euronext\u00a0: IPN\u00a0: ADR\u00a0: IPSEY) et Albireo (Nasdaq\u00a0: ALBO) ont annonc\u00e9 aujourd\u2019hui avoir conclu un accord de fusion d\u00e9finitif aux termes duquel Ipsen acquiert Albireo, une entreprise innovante de premier plan dans le domaine des modulateurs d\u2019acides biliaires pour le traitement des maladies h\u00e9patiques cholestatiques chez l\u2019enfant et l\u2019adulte. L\u2019 acquisition pr\u00e9vue permettra ainsi \u00e0 Ipsen de renforcer son portefeuille de produits commercialis\u00e9s et de produits en R&amp;D dans les Maladies Rares.<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[],"tags":[],"class_list":["post-1619","press_release","type-press_release","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ipsen acquiert Albireo, pour acc\u00e9l\u00e9rer sa croissance dans les Maladies Rares afin de traiter les maladies du foie chez l\u2019enfant - Annual Report<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen acquiert Albireo, pour acc\u00e9l\u00e9rer sa croissance dans les Maladies Rares afin de traiter les maladies du foie chez l\u2019enfant - Annual Report\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/\" \/>\n<meta property=\"og:site_name\" content=\"Annual Report\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-23T14:11:18+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/\",\"url\":\"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/\",\"name\":\"Ipsen acquiert Albireo, pour acc\u00e9l\u00e9rer sa croissance dans les Maladies Rares afin de traiter les maladies du foie chez l\u2019enfant - Annual Report\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/annualreport\/#website\"},\"datePublished\":\"2023-01-09T07:00:00+00:00\",\"dateModified\":\"2023-05-23T14:11:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/annualreport\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ipsen acquiert Albireo, pour acc\u00e9l\u00e9rer sa croissance dans les Maladies Rares afin de traiter les maladies du foie chez l\u2019enfant\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/annualreport\/#website\",\"url\":\"https:\/\/www.ipsen.com\/annualreport\/\",\"name\":\"Annual Report\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/annualreport\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/annualreport\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/annualreport\/#organization\",\"name\":\"Annual Report\",\"url\":\"https:\/\/www.ipsen.com\/annualreport\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/annualreport\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/3\/2023\/12\/07162703\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/3\/2023\/12\/07162703\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"Annual Report\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/annualreport\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen acquiert Albireo, pour acc\u00e9l\u00e9rer sa croissance dans les Maladies Rares afin de traiter les maladies du foie chez l\u2019enfant - Annual Report","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/","og_locale":"fr_FR","og_type":"article","og_title":"Ipsen acquiert Albireo, pour acc\u00e9l\u00e9rer sa croissance dans les Maladies Rares afin de traiter les maladies du foie chez l\u2019enfant - Annual Report","og_url":"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/","og_site_name":"Annual Report","article_modified_time":"2023-05-23T14:11:18+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/","url":"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/","name":"Ipsen acquiert Albireo, pour acc\u00e9l\u00e9rer sa croissance dans les Maladies Rares afin de traiter les maladies du foie chez l\u2019enfant - Annual Report","isPartOf":{"@id":"https:\/\/www.ipsen.com\/annualreport\/#website"},"datePublished":"2023-01-09T07:00:00+00:00","dateModified":"2023-05-23T14:11:18+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-acquiert-albireo-pour-accelerer-sa-croissance-dans-les-maladies-rares-afin-de-traiter-les-maladies-du-foie-chez-lenfant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/annualreport\/fr\/"},{"@type":"ListItem","position":2,"name":"Ipsen acquiert Albireo, pour acc\u00e9l\u00e9rer sa croissance dans les Maladies Rares afin de traiter les maladies du foie chez l\u2019enfant"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/annualreport\/#website","url":"https:\/\/www.ipsen.com\/annualreport\/","name":"Annual Report","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/annualreport\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/annualreport\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/annualreport\/#organization","name":"Annual Report","url":"https:\/\/www.ipsen.com\/annualreport\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/annualreport\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/3\/2023\/12\/07162703\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/3\/2023\/12\/07162703\/Latest_Ipsen-logo_168x48.svg","caption":"Annual Report"},"image":{"@id":"https:\/\/www.ipsen.com\/annualreport\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/annualreport\/fr\/wp-json\/wp\/v2\/press_release\/1619"}],"collection":[{"href":"https:\/\/www.ipsen.com\/annualreport\/fr\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.ipsen.com\/annualreport\/fr\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/annualreport\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":0,"href":"https:\/\/www.ipsen.com\/annualreport\/fr\/wp-json\/wp\/v2\/press_release\/1619\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/annualreport\/fr\/wp-json\/wp\/v2\/media?parent=1619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/annualreport\/fr\/wp-json\/wp\/v2\/categories?post=1619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/annualreport\/fr\/wp-json\/wp\/v2\/tags?post=1619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}